More Than Half of Americans are Unfamiliar with Chronic Kidney Disease, Survey Finds

Chronic kidney disease (CKD) is a major blind spot for many Americans, a new survey suggests.

The poll, conducted by the Global Coalition on Aging, asked 1,000 American adults about their understanding and perception of CKD.

Though many respondents used the internet for medical information and had a regular doctor and blood work done once or twice a year, 58% of respondents said they were unfamiliar with the illness.

More than half of respondents had not thought about CKD at all, while a fifth had thought about it but had done no research, the coalition found. Only 9% had done a lot of research. At the same time, more than half were not concerned with managing CKD if diagnosed with it.

“People tend to deny their personal needs when it comes to chronic disease, which this survey reflected,” Michael Hodin, CEO of the Global Coalition on Aging, told Fierce Healthcare in an emailed Q&A. “We’ve never fully understood how to shift from communicable to noncommunicable diseases in terms of attitudes, awareness, behaviors.”

More than 1 in 7 U.S. adults, or 35.5 million people, are estimated to have CKD. CKD is a “silent” disease, with many symptoms not appearing until advanced stages of the disease.

If a doctor were to deliver a message that “250,000 die each year, simple tests covered by insurance,” 60% of respondents would be motivated to get the tests, per the poll. If suggested by a spouse, just over a third of respondents were motivated.

Respondents over the age of 60, who are at greatest risk of the disease, were less familiar with CKD than younger respondents, even though they’re more likely to see a doctor twice a year. Greater awareness among young people could be attributed to social media exposure, which is where there is more attention to issues like CKD, Hodin said.

The consequence of many Americans not understanding CKD is “less healthy aging,” Hodin said. “When a chronic disease like CKD goes untreated, those patients will then require acute, emergency care, which is worse for them and adds cost and burden to the system,” he said.

The Global Coalition on Healthy Aging recommends creating roundtable discussions with relevant stakeholders, including CKD in blood screenings and other preventive actions and using social media to spread awareness. Additionally, it recommends building CKD information and risk attention into health programs of age-friendly cities, integrated care approaches and long-term care settings. And finally, it recommended working with employers to develop communication awareness for employees and their families.

Source: Fierce Healthcare

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.